{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:20:21Z","timestamp":1768569621903,"version":"3.49.0"},"posted":{"date-parts":[[2025,10,27]]},"group-title":"Neurology","reference-count":92,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Alzheimer\u2019s disease (AD) involves early molecular changes beyond amyloid-\u03b2 (A\u03b2) and tau, that create heterogeneous disease biology, giving rise to variable disease initiation and highly variable longitudinal trajectories. Accurately predicting trajectories is vital for design of clinical trials and for clinical care, yet current CSF and PET biomarkers provide limited predictive capabilities despite their excellent diagnostic value. We performed CSF proteomics using tandem-mass-tag mass spectrometry in 1,104 ADNI participants with extensive longitudinal assessments. Machine learning\u2013derived protein panels accurately predicted two classes of outcomes. First, they identified several key inflection points along the disease trajectory, including onset of 1) amyloid plaque pathology (A\u03b2- to A\u03b2+; AUC=0.88), 2) symptoms (asymptomatic to symptomatic; AUC=0.89), and 3) functional decline (MCI [due-to-AD] to AD Dementia; AUC=0.88). Second, protein panels forecast longitudinal trajectories of decline, spanning both clinical domains (cognition and function) and pathological process, including tau accumulation measured by tau-PET neocortical standardized uptake value ratio (SUVR) and neurodegeneration indexed by hippocampal volume and FDG-PET SUVR. Proteomics panels outperformed conventional CSF- and PET-based A\u03b2 and tau markers. Importantly, these predictions were driven by novel mechanisms, spanning synaptic signaling, proteostasis, metabolic stress, vascular remodeling, and immune dysregulation, that anchor distinct inflection points and shape long-term trajectories. Together, these findings position CSF proteomics as a powerful approach for anticipating disease onset and progression, with direct implications for patient stratification and personalized intervention.<\/jats:p>","DOI":"10.1101\/2025.10.24.25337921","type":"posted-content","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:50:16Z","timestamp":1761580216000},"source":"Crossref","is-referenced-by-count":1,"title":["Cerebrospinal fluid proteomics for predictive assessment of Alzheimer\u2019s Disease risk"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4752-2298","authenticated-orcid":false,"given":"Saima","family":"Rathore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2947-7606","authenticated-orcid":false,"given":"Eric B.","family":"Dammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1384-941X","authenticated-orcid":false,"given":"Anantharaman","family":"Shantaraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duc M.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik C. B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Lah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-624X","authenticated-orcid":false,"given":"Nicholas T.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan I.","family":"Levey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025102921550527000_2025.10.24.25337921v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"2025102921550527000_2025.10.24.25337921v1.2","doi-asserted-by":"crossref","unstructured":"Serrano-Pozo, A. , Frosch, M. P. , Masliah, E. & Hyman, B. T . Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 1, a006189 (2011).","DOI":"10.1101\/cshperspect.a006189"},{"key":"2025102921550527000_2025.10.24.25337921v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70291-0"},{"key":"2025102921550527000_2025.10.24.25337921v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-006-0127-z"},{"key":"2025102921550527000_2025.10.24.25337921v1.5","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e318232a379"},{"key":"2025102921550527000_2025.10.24.25337921v1.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05258-7"},{"key":"2025102921550527000_2025.10.24.25337921v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15436-0"},{"key":"2025102921550527000_2025.10.24.25337921v1.8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s43587-024-00731-y","article-title":"Diagnosis of Alzheimer\u2019s disease using plasma biomarkers adjusted to clinical probability","volume":"4","year":"2024","journal-title":"Nat Aging"},{"key":"2025102921550527000_2025.10.24.25337921v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02443-z"},{"key":"2025102921550527000_2025.10.24.25337921v1.10","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1002\/alz.13164","article-title":"Profiling and predicting distinct tau progression patterns: An unsupervised data-driven approach to flortaucipir positron emission tomography","volume":"19","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2025102921550527000_2025.10.24.25337921v1.11","doi-asserted-by":"crossref","unstructured":"Rathore, S. et al. Predicting regional tau accumulation with machine learning-based tau-PET and advanced radiomics. Alzheimer\u2019s and Dementia: Translational Research and Clinical Intervention TR C270005, (2024).","DOI":"10.1002\/trc2.70005"},{"key":"2025102921550527000_2025.10.24.25337921v1.12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jamaneurol.2024.1612","article-title":"Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment","volume":"81","year":"2024","journal-title":"JAMA Neurol"},{"key":"2025102921550527000_2025.10.24.25337921v1.13","doi-asserted-by":"crossref","unstructured":"Rathore, S. et al. Regional tau PET patterns predict prospective domain-specific cognitive decline in early symptomatic Alzheimer\u2019s disease. Alzheimers Res Ther 17, 220 (2025).","DOI":"10.1186\/s13195-025-01868-7"},{"key":"2025102921550527000_2025.10.24.25337921v1.14","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamaneurol.2024.0991","article-title":"Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial","volume":"81","year":"2024","journal-title":"JAMA Neurol"},{"key":"2025102921550527000_2025.10.24.25337921v1.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2305032"},{"key":"2025102921550527000_2025.10.24.25337921v1.16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/alz.12748","article-title":"The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer\u2019s disease","volume":"19","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2025102921550527000_2025.10.24.25337921v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00999-y"},{"key":"2025102921550527000_2025.10.24.25337921v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/S41591-020-0815-6"},{"key":"2025102921550527000_2025.10.24.25337921v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-018-0154-9"},{"key":"2025102921550527000_2025.10.24.25337921v1.20","doi-asserted-by":"crossref","unstructured":"Neff, R. A. et al. Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv 7, (2021).","DOI":"10.1126\/sciadv.abb5398"},{"key":"2025102921550527000_2025.10.24.25337921v1.21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cels.2016.11.006","article-title":"A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer\u2019s Disease","volume":"4","year":"2017","journal-title":"Cell Syst"},{"key":"2025102921550527000_2025.10.24.25337921v1.22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09613-z"},{"key":"2025102921550527000_2025.10.24.25337921v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-020-0635-5"},{"key":"2025102921550527000_2025.10.24.25337921v1.24","doi-asserted-by":"crossref","unstructured":"Watson, C. M. et al. Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer\u2019s Disease. Sci Data 10, 261 (2023).","DOI":"10.1038\/s41597-023-02158-3"},{"key":"2025102921550527000_2025.10.24.25337921v1.25","doi-asserted-by":"publisher","DOI":"10.1101\/2025.10.08.25337413"},{"key":"2025102921550527000_2025.10.24.25337921v1.26","doi-asserted-by":"crossref","unstructured":"Tandon, R. et al. Stratifying risk of Alzheimer\u2019s disease in healthy middle-aged individuals with machine learning. Brain Commun 7, fcaf121 (2025).","DOI":"10.1093\/braincomms\/fcaf121"},{"key":"2025102921550527000_2025.10.24.25337921v1.27","doi-asserted-by":"crossref","unstructured":"Haque, R. et al. A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer\u2019s disease. Sci Transl Med 15, eadg4122 (2023).","DOI":"10.1126\/scitranslmed.adg4122"},{"key":"2025102921550527000_2025.10.24.25337921v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12897"},{"key":"2025102921550527000_2025.10.24.25337921v1.29","doi-asserted-by":"crossref","unstructured":"Johnson, E. C. B. et al. Deep proteomic network analysis of Alzheimer\u2019s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease. Mol Neurodegener 13, 52 (2018).","DOI":"10.1186\/s13024-018-0282-4"},{"key":"2025102921550527000_2025.10.24.25337921v1.30","doi-asserted-by":"crossref","unstructured":"Ping, L. et al. Global quantitative analysis of the human brain proteome in Alzheimer\u2019s and Parkinson\u2019s Disease. Sci Data 5, 180036 (2018).","DOI":"10.1038\/sdata.2018.36"},{"key":"2025102921550527000_2025.10.24.25337921v1.31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuroscience.2011.03.059","article-title":"Protective effects of bone morphogenetic protein 7 against amyloid-beta induced neurotoxicity in PC12 cells","volume":"184","year":"2011","journal-title":"Neuroscience"},{"key":"2025102921550527000_2025.10.24.25337921v1.32","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2722280\/v1"},{"key":"2025102921550527000_2025.10.24.25337921v1.33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.420224"},{"key":"2025102921550527000_2025.10.24.25337921v1.34","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201541218"},{"key":"2025102921550527000_2025.10.24.25337921v1.35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3233\/JAD-160220","article-title":"Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer\u2019s Disease Patients","volume":"53","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"2025102921550527000_2025.10.24.25337921v1.36","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010933404324"},{"key":"2025102921550527000_2025.10.24.25337921v1.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1996.tb02080.x"},{"key":"2025102921550527000_2025.10.24.25337921v1.38","unstructured":"38. Lundberg, S. M. & Lee, S.-I. A Unified Approach to Interpreting Model Predictions. in Advances in Neural Information Processing Systems (eds. Guyon, I. et al.) vol. 30 (Curran Associates, Inc., 2017)."},{"key":"2025102921550527000_2025.10.24.25337921v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.55"},{"key":"2025102921550527000_2025.10.24.25337921v1.40","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70079"},{"key":"2025102921550527000_2025.10.24.25337921v1.41","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awy050"},{"key":"2025102921550527000_2025.10.24.25337921v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02476-4"},{"key":"2025102921550527000_2025.10.24.25337921v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70355-6"},{"key":"2025102921550527000_2025.10.24.25337921v1.44","doi-asserted-by":"publisher","DOI":"10.1007\/S13311-022-01185-Z"},{"key":"2025102921550527000_2025.10.24.25337921v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2023.03.005"},{"key":"2025102921550527000_2025.10.24.25337921v1.46","doi-asserted-by":"crossref","first-page":"400","DOI":"10.14283\/jpad.2022.49","article-title":"Prediction of Cognitive Decline for Enrichment of Alzheimer\u2019s Disease Clinical Trials","volume":"9","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"2025102921550527000_2025.10.24.25337921v1.47","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300410"},{"key":"2025102921550527000_2025.10.24.25337921v1.48","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa248"},{"key":"2025102921550527000_2025.10.24.25337921v1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2009.07.002"},{"key":"2025102921550527000_2025.10.24.25337921v1.50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.dadm.2018.02.003","article-title":"Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid \u03b2 positron emission tomography pathology","volume":"10","year":"2018","journal-title":"Alzheimers Dement (Amst"},{"key":"2025102921550527000_2025.10.24.25337921v1.51","doi-asserted-by":"crossref","unstructured":"La Joie, R. et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med 12, (2020).","DOI":"10.1126\/scitranslmed.aau5732"},{"key":"2025102921550527000_2025.10.24.25337921v1.52","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx243"},{"key":"2025102921550527000_2025.10.24.25337921v1.53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.14283\/jpad.2019.14","article-title":"Anti-Tau Trials for Alzheimer\u2019s Disease: A Report from the EU\/US\/CTAD Task Force","volume":"6","year":"2019","journal-title":"J Prev Alzheimers Dis"},{"key":"2025102921550527000_2025.10.24.25337921v1.54","doi-asserted-by":"crossref","unstructured":"Jadhav, S. et al. A walk through tau therapeutic strategies. Acta Neuropathol Commun 7, 22 (2019).","DOI":"10.1186\/s40478-019-0664-z"},{"key":"2025102921550527000_2025.10.24.25337921v1.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJ-Moa2212948"},{"key":"2025102921550527000_2025.10.24.25337921v1.56","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2100708"},{"key":"2025102921550527000_2025.10.24.25337921v1.57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.13239"},{"key":"2025102921550527000_2025.10.24.25337921v1.58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-013-1323-3","article-title":"The diverse roles of calcium-binding protein regucalcin in cell biology: from tissue expression and signalling to disease","volume":"71","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"2025102921550527000_2025.10.24.25337921v1.59","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13033"},{"key":"2025102921550527000_2025.10.24.25337921v1.60","doi-asserted-by":"crossref","unstructured":"Janciauskiene, S. , Lechowicz, U. , Pelc, M. , Olejnicka, B. & Chorostowska-Wynimko, J . Diagnostic and therapeutic value of human serpin family proteins. Biomed Pharmacother 175, 116618 (2024).","DOI":"10.1016\/j.biopha.2024.116618"},{"key":"2025102921550527000_2025.10.24.25337921v1.61","doi-asserted-by":"crossref","unstructured":"Lenda, R. , Padjasek, M. , Kr\u0119\u017cel, A. , O\u017cyhar, A. & Bystranowska, D . Does one plus one always equal two? Structural differences between nesfatin-1, -2, and nesfatin-1\/2. Cell Commun Signal 20, 163 (2022).","DOI":"10.1186\/s12964-022-00980-7"},{"key":"2025102921550527000_2025.10.24.25337921v1.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"2025102921550527000_2025.10.24.25337921v1.63","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12295"},{"key":"2025102921550527000_2025.10.24.25337921v1.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"2025102921550527000_2025.10.24.25337921v1.65","doi-asserted-by":"crossref","unstructured":"Luquez, T. et al. Cell type-specific changes identified by single-cell transcriptomics in Alzheimer\u2019s disease. Genome Med 14, 136 (2022).","DOI":"10.1186\/s13073-022-01136-5"},{"key":"2025102921550527000_2025.10.24.25337921v1.66","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1195-2"},{"key":"2025102921550527000_2025.10.24.25337921v1.67","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1305-10.2010"},{"key":"2025102921550527000_2025.10.24.25337921v1.68","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-328X(03)00283-3"},{"key":"2025102921550527000_2025.10.24.25337921v1.69","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3233\/JAD-171174","article-title":"Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort","volume":"65","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"2025102921550527000_2025.10.24.25337921v1.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2021.04.031"},{"key":"2025102921550527000_2025.10.24.25337921v1.71","doi-asserted-by":"crossref","unstructured":"Wang, Z. , Zhao, B. & Jia, J . Gantenerumab in Early Alzheimer\u2019s Disease. N Engl J Med 390, 866 (2024).","DOI":"10.1056\/NEJMc2314291"},{"key":"2025102921550527000_2025.10.24.25337921v1.72","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-024-01737-w"},{"key":"2025102921550527000_2025.10.24.25337921v1.73","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3631708\/v1"},{"key":"2025102921550527000_2025.10.24.25337921v1.74","doi-asserted-by":"crossref","unstructured":"Higginbotham, L. et al. Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer\u2019s Disease. Proteomes 7, (2019).","DOI":"10.3390\/proteomes7030030"},{"key":"2025102921550527000_2025.10.24.25337921v1.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2014.07.028"},{"key":"2025102921550527000_2025.10.24.25337921v1.76","doi-asserted-by":"crossref","unstructured":"Ross, J. A. & Dodel, R . Preclinical CSF proteomic changes: a milestone in biomarker detection for autosomal dominant Alzheimer\u2019s disease. Signal Transduct Target Ther 10, 16 (2025).","DOI":"10.1038\/s41392-024-02109-3"},{"key":"2025102921550527000_2025.10.24.25337921v1.77","doi-asserted-by":"crossref","unstructured":"Arnsten, A. F. T. et al. Dysregulated calcium signaling in the aged primate association cortices: vulnerability to Alzheimer\u2019s disease neuropathology. Front Aging Neurosci 17, 1610350 (2025).","DOI":"10.3389\/fnagi.2025.1610350"},{"key":"2025102921550527000_2025.10.24.25337921v1.78","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.12374"},{"key":"2025102921550527000_2025.10.24.25337921v1.79","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4256"},{"key":"2025102921550527000_2025.10.24.25337921v1.80","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.TIR120.002048"},{"key":"2025102921550527000_2025.10.24.25337921v1.81","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth1113"},{"key":"2025102921550527000_2025.10.24.25337921v1.82","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40129-9"},{"key":"2025102921550527000_2025.10.24.25337921v1.83","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14360"},{"key":"2025102921550527000_2025.10.24.25337921v1.84","doi-asserted-by":"crossref","unstructured":"Dammer, E. B. , Seyfried, N. T. & Johnson, E. C. B . Batch Correction and Harmonization of -Omics Datasets with a Tunable Median Polish of Ratio. Frontiers in systems biology 3, (2023).","DOI":"10.3389\/fsysb.2023.1092341"},{"key":"2025102921550527000_2025.10.24.25337921v1.85","first-page":"e1","article-title":"Recent publications from the Alzheimer\u2019s Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials","volume":"13","year":"2017","journal-title":"Alzheimers Dement"},{"key":"2025102921550527000_2025.10.24.25337921v1.86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.09.172"},{"key":"2025102921550527000_2025.10.24.25337921v1.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.01.021"},{"key":"2025102921550527000_2025.10.24.25337921v1.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.05.056"},{"key":"2025102921550527000_2025.10.24.25337921v1.89","doi-asserted-by":"crossref","unstructured":"Pablo Aguilar Dominguez et al. Evaluation of PVC methods on head-to-head FTP and MK6240. ALZHEIMER\u2019S IMAGING CONSORTIUM (2022).","DOI":"10.1002\/alz.065914"},{"key":"2025102921550527000_2025.10.24.25337921v1.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"2025102921550527000_2025.10.24.25337921v1.91","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v067.i0"},{"key":"2025102921550527000_2025.10.24.25337921v1.92","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.10.24.25337921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:49:34Z","timestamp":1768510174000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.10.24.25337921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":92,"URL":"https:\/\/doi.org\/10.1101\/2025.10.24.25337921","relation":{},"subject":[],"published":{"date-parts":[[2025,10,27]]},"subtype":"preprint"}}